Dried plasma spots as an alternative sample collection technique for the quantitative LC-MS/MS determination of gabapentin

被引:44
作者
Kolocouri, Filomila [1 ]
Dotsikas, Yannis [1 ]
Loukas, Yannis L. [1 ]
机构
[1] Univ Athens, Div Pharmaceut Chem, Dept Pharm, GR-15771 Athens, Greece
关键词
Dried plasma spots; Butanol/HCl; Gabapentin; Spot homogeneity; Mass spectrometry; PERFORMANCE LIQUID-CHROMATOGRAPHY; SOLID-PHASE EXTRACTION; TANDEM MASS-SPECTROMETRY; HUMAN SERUM; DOSAGE FORMS; SPECTROFLUOROMETRIC DETERMINATION; CAPILLARY-ELECTROPHORESIS; PRECOLUMN DERIVATIZATION; FLUORESCENCE DETECTION; FLUOROMETRIC DETECTION;
D O I
10.1007/s00216-010-4048-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Dried plasma spots were employed as an alternative sample collection technique for the quantitative determination of gabapentin in human plasma, using an automated liquid chromatography tandem mass spectrometry method. After the methanolic extraction of single plasma, 1/8-in. disks which contained only 1.98 mu L plasma volume, were placed in 96-well format plates, then gabapentin and its internal standard, 4-aminocyclohexanecarboxylic acid, were derivatized with n-butanol/HCl (3 M) and detected as butyl esters. The assay exhibited excellent linearity over the concentration range of 40.0-10.0 x 10(3) ng/mL, which is suitable for the determination of gabapentin after per os administration of a single tablet. Variations in intra- and inter-assay accuracy and precision were within internationally accepted criteria. Homogeneity of plasma spots was proven, whilst butyl ester stability for both analytes was estimated and found very satisfactory. The quantitative analysis of Gabapentin with dried plasma spot specimens seems to be a prominent and advantageous technique, especially when applied to pharmacokinetic studies, where plasma sampling procedure becomes rapid and required plasma volumes negligible.
引用
收藏
页码:1339 / 1347
页数:9
相关论文
共 55 条
  • [2] Al-Zehouri J, 2001, ARZNEIMITTEL-FORSCH, V51, P97
  • [3] [Anonymous], 2001, Guidance for industry: bioanalytical method validation
  • [4] Quantitative determination of donepezil in human plasma by liquid chromatography/tandem mass spectrometry employing an automated liquid-liquid extraction based on 96-well format plates - Application to a bioequivalence study
    Apostolou, Constantinos
    Dotsikas, Yannis
    Kousoulos, Constantinos
    Loukas, Yannis L.
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 848 (02): : 239 - 244
  • [5] Use of dried spots of whole blood, plasma, and mother's milk collected on filter paper for measurement of human immunodeficiency virus type 1 burden
    Ayele, Workenesh
    Schuurman, Rob
    Messele, Tsehaynesh
    Dorigo-Zetsma, Wendelien
    Mengistu, Yohannes
    Goudsmit, Jaap
    Paxton, William A.
    de Baar, Michel P.
    Pollakis, Georgios
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (03) : 891 - 896
  • [6] Sensitive high-performance liquid chromatographic quantitation of gabapentin in human serum using liquid-liquid extraction and pre-column derivatization with 9-fluorenylmethyl chloroformate
    Bahrami, G
    Kiani, A
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2006, 835 (1-2): : 123 - 126
  • [7] Spectrofluorimetric determination of vigabatrin and gabapentin in urine and dosage forms through derivatization with fluorescamine
    Belal, F
    Abdine, H
    Al-Majed, A
    Khalil, NY
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 27 (1-2) : 253 - 260
  • [8] Quantitative determination of vigabatrin and gabapentin in human serum by gas chromatography-mass spectrometry
    Borrey, DCR
    Godderis, KO
    Engelrelst, VIL
    Bernard, DR
    Langlois, MR
    [J]. CLINICA CHIMICA ACTA, 2005, 354 (1-2) : 147 - 151
  • [9] Sample preparation and determination of gabapentin in venous and capillary blood using liquid chromatography-tandem mass spectrometry
    Carlsson, KC
    Reubsaet, JLE
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 34 (02) : 415 - 423
  • [10] Mass spectrometry in newborn and metabolic screening: historical perspective and future directions
    Chace, Donald H.
    [J]. JOURNAL OF MASS SPECTROMETRY, 2009, 44 (02): : 163 - 170